BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3510091)

  • 1. Plasma cholinesterase phenotyping with use of visible-region spectrophotometry.
    Abernethy MH; George PM; Herron JL; Evans RT
    Clin Chem; 1986 Jan; 32(1 Pt 1):194-7. PubMed ID: 3510091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cholinesterase genetic variants phenotyped using a Cobas-Fara centrifugal analyser.
    Brock A
    J Clin Chem Clin Biochem; 1988 Dec; 26(12):873-5. PubMed ID: 3235960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of serum cholinesterase with succinylcholine and propionylthiocholine as substrates.
    Wakid NW; Tubbeh R; Baraka A
    Anesthesiology; 1985 Apr; 62(4):509-12. PubMed ID: 3885794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a commercially available assay system with two reference methods for the determination of plasma cholinesterase variants.
    Whittaker M; Britten JJ; Dawson PJ
    Clin Chem; 1983 Oct; 29(10):1746-51. PubMed ID: 6616819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinesterase assay automated in the Cobas-Bio centrifugal analyzer.
    Ratnaike S; Gray F; Deam D
    Clin Chem; 1987 Aug; 33(8):1460-2. PubMed ID: 3608167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new succinylcholine-based assay of plasma cholinesterase.
    Abernethy MH; George PM; Melton VE
    Clin Chem; 1984 Feb; 30(2):192-5. PubMed ID: 6362911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of some methods of phenotyping the plasma cholinesterase variants using benzoylcholine as substrate.
    Whittaker M; Britten JJ
    Ann Clin Biochem; 1981 Jan; 18(Pt 1):9-14. PubMed ID: 7259066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scope and limitations of propionylthiocholinesterase in the characterisation of cholinesterase variants.
    Price EM; Brown SS
    Clin Biochem; 1975 Dec; 8(6):384-90. PubMed ID: 1204213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The temperature activity relationships of serum cholinesterases.
    King J; Morgan HG
    J Clin Pathol; 1970 Nov; 23(8):730-2. PubMed ID: 5488048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged response to succinylcholine: a new variant of plasma cholinesterase that is identified as normal by traditional phenotyping methods.
    Greenberg CP; Primo-Parmo SL; Pantuck EJ; la Du BN
    Anesth Analg; 1995 Aug; 81(2):419-21. PubMed ID: 7618741
    [No Abstract]   [Full Text] [Related]  

  • 11. [A spectrophotometric method for the determination of serum cholinesterase variants with succinyl choline as substrate (author's transl)].
    Agarwal DP; Schwenkenbecher S; Srivastava LM; Goedde HW
    Z Klin Chem Klin Biochem; 1975 Apr; 13(4):133-5. PubMed ID: 168694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New enzymatic assay of cholinesterase activity.
    Okabe H; Sagesaka K; Nakajima N; Noma A
    Clin Chim Acta; 1977 Oct; 80(1):87-94. PubMed ID: 20253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorimetric determination of serum cholinesterase and its genetic variants by the propionylthiocholine-dithiobis(nitrobenzoic acid)procedure.
    Dietz AA; Rubinstein HM; Lubrano T
    Clin Chem; 1973 Nov; 19(11):1309-13. PubMed ID: 4758610
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of two substrates in determination of plasma cholinesterase activity & genetic variability.
    Verma M; Singh S; Nain CK; Ganguly NK; Sharma BK
    Indian J Med Res; 1996 Aug; 104():198-200. PubMed ID: 8840660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of serum cholinesterase activity and dibucaine numbers by an amperometric choline sensor.
    Palleschi G; Lavagnini MG; Moscone D; Pilloton R; D'Ottavio D; Evangelisti ME
    Biosens Bioelectron; 1990; 5(1):27-35. PubMed ID: 2178637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay using succinyldithiocholine as substrate: the method of choice for the measurement of cholinesterase catalytic activity in serum to diagnose succinyldicholine sensitivity.
    Mosca A; Bonora R; Ceriotti F; Franzini C; Lando G; Patrosso MC; Zaninotto M; Panteghini M;
    Clin Chem Lab Med; 2003 Mar; 41(3):317-22. PubMed ID: 12705341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the plasma cholinesterase variants by propranolol.
    Whittaker M; Britten JJ; Wicks RJ
    Br J Anaesth; 1981 May; 53(5):511-6. PubMed ID: 7236476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved method for the identification of the fluoride-resistant plasmacholinesterase genotypes.
    Zsigmond EK; Flynn KB; Kothary SP
    Biochem Genet; 1980 Oct; 18(9-10):861-7. PubMed ID: 7225083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of stepwise discriminant analysis in the phenotyping of plasma cholinesterase variants.
    Turner JM; Hall RA; Whittaker M; Holder RL; Kricka LJ
    Ann Clin Biochem; 1985 Mar; 22 ( Pt 2)():175-8. PubMed ID: 4004108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrolysis of suxamethonium by different types of plasma.
    Hobbiger F; Peck AW
    Br J Pharmacol; 1969 Sep; 37(1):258-71. PubMed ID: 4981001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.